These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8654684)

  • 1. Immunoliposome-mediated targeting of anti-cancer drugs in vivo.
    Allen TM; Ahmad I; Lopes de Menezes DE; Moase EH
    Biochem Soc Trans; 1995 Nov; 23(4):1073-9. PubMed ID: 8654684
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-MUC-1 immunoliposomal doxorubicin in the treatment of murine models of metastatic breast cancer.
    Moase EH; Qi W; Ishida T; Gabos Z; Longenecker BM; Zimmermann GL; Ding L; Krantz M; Allen TM
    Biochim Biophys Acta; 2001 Feb; 1510(1-2):43-55. PubMed ID: 11342146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo targeting of immunoliposomal doxorubicin to human B-cell lymphoma.
    Lopes de Menezes DE; Pilarski LM; Allen TM
    Cancer Res; 1998 Aug; 58(15):3320-30. PubMed ID: 9699662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PEG-immunoliposome.
    Maruyama K
    Biosci Rep; 2002 Apr; 22(2):251-66. PubMed ID: 12428903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FK317, a novel substituted dihydrobenzoxazine, exhibits potent antitumor activity against human tumor xenografts in nude mice.
    Naoe Y; Inami M; Matsumoto S; Takagaki S; Fujiwara T; Yamazaki S; Kawamura I; Nishigaki F; Tsujimoto S; Manda T; Shimomura K
    Jpn J Cancer Res; 1998 Dec; 89(12):1306-17. PubMed ID: 10081492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoliposome-mediated targeting of doxorubicin to human ovarian carcinoma in vitro and in vivo.
    Vingerhoeds MH; Steerenberg PA; Hendriks JJ; Dekker LC; Van Hoesel QG; Crommelin DJ; Storm G
    Br J Cancer; 1996 Oct; 74(7):1023-9. PubMed ID: 8855969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery.
    Park JW; Hong K; Kirpotin DB; Colbern G; Shalaby R; Baselga J; Shao Y; Nielsen UB; Marks JD; Moore D; Papahadjopoulos D; Benz CC
    Clin Cancer Res; 2002 Apr; 8(4):1172-81. PubMed ID: 11948130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-cancer activity of 9-nitrocamptothecin liposome aerosol in mice.
    Knight V; Koshkina N; Waldrep C; Giovanella BC; Kleinerman E; Gilbert B
    Trans Am Clin Climatol Assoc; 2000; 111():135-45. PubMed ID: 10881338
    [No Abstract]   [Full Text] [Related]  

  • 9. [New approaches in experimental cancerology: in search of therapeutic models].
    Guilbaud N; Kraus-Berthier L; Meyer-Losic F; Pierré A; Hickman J
    Bull Cancer; 2001 Jan; 88(1):75-84. PubMed ID: 11182656
    [No Abstract]   [Full Text] [Related]  

  • 10. Monoclonal antibody Po66 uptake by human lung tumours implanted in nude mice: effect of co-administration with doxorubicin.
    Desrues B; Léna H; Brichory F; Ramée MP; Toujas L; Delaval P; Dazord L
    Br J Cancer; 1995 Nov; 72(5):1076-82. PubMed ID: 7577450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study on third-type immunoliposomes loaded drugs and the targeting in vitro and in vivo].
    Hou XP; Zhang YF; Xie SS; Hu X
    Yao Xue Xue Bao; 2001 Jul; 36(7):539-42. PubMed ID: 12585089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody targeting of doxorubicin-loaded liposomes suppresses the growth and metastatic spread of established human lung tumor xenografts in severe combined immunodeficient mice.
    Sugano M; Egilmez NK; Yokota SJ; Chen FA; Harding J; Huang SK; Bankert RB
    Cancer Res; 2000 Dec; 60(24):6942-9. PubMed ID: 11156394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidermal growth factor receptor-targeted immunoliposomes significantly enhance the efficacy of multiple anticancer drugs in vivo.
    Mamot C; Drummond DC; Noble CO; Kallab V; Guo Z; Hong K; Kirpotin DB; Park JW
    Cancer Res; 2005 Dec; 65(24):11631-8. PubMed ID: 16357174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Doxorubicin conjugated with a monoclonal antibody directed to a human melanoma-associated proteoglycan suppresses the growth of established tumor xenografts in nude mice.
    Yang HM; Reisfeld RA
    Proc Natl Acad Sci U S A; 1988 Feb; 85(4):1189-93. PubMed ID: 3422487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor activity of sequential treatment with topotecan and anti-epidermal growth factor receptor monoclonal antibody C225.
    Ciardiello F; Bianco R; Damiano V; De Lorenzo S; Pepe S; De Placido S; Fan Z; Mendelsohn J; Bianco AR; Tortora G
    Clin Cancer Res; 1999 Apr; 5(4):909-16. PubMed ID: 10213228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cure of xenografted human carcinomas by BR96-doxorubicin immunoconjugates.
    Trail PA; Willner D; Lasch SJ; Henderson AJ; Hofstead S; Casazza AM; Firestone RA; Hellström I; Hellström KE
    Science; 1993 Jul; 261(5118):212-5. PubMed ID: 8327892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapeutic profiles of human tumors implanted in SCID mice showing appreciable inconsistencies with those in nude mice.
    Yoshimura M; Endo S; Hioki K; Ueyama Y; Ohnishi Y
    Exp Anim; 1997 Apr; 46(2):153-6. PubMed ID: 9145296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody-targeted delivery of doxorubicin entrapped in sterically stabilized liposomes can eradicate lung cancer in mice.
    Ahmad I; Longenecker M; Samuel J; Allen TM
    Cancer Res; 1993 Apr; 53(7):1484-8. PubMed ID: 8453612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Target therapy by monoclonal antibody against ovarian carcinoma conjugated with liposome and adriamycin].
    Li WJ; Qian HN; Lu WY
    Zhonghua Fu Chan Ke Za Zhi; 1994 May; 29(5):296-8, 319. PubMed ID: 7956556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disposition of conjugate-bound and free doxorubicin in tumor-bearing mice following administration of a BR96-doxorubicin immunoconjugate (BMS 182248).
    Mosure KW; Henderson AJ; Klunk LJ; Knipe JO
    Cancer Chemother Pharmacol; 1997; 40(3):251-8. PubMed ID: 9219510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.